Maven Securities’s ChemoCentryx, Inc. CCXI Stock Holding History

Maven Securities’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,000	Closed	-$207K	–	1199
2022 Q3	$207K	Buy	+4,000	New	+$165K	﹤0.01%	1046
2022 Q2	–	Sell	-86,638	Closed	-$2.17M	–	1177
2022 Q1	$2.17M	Buy	86,638 +22,802	+36%	+$641K	0.08%	173
2021 Q4	$2.32M	Buy	+63,836	New	+$2.24M	0.07%	167

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Maven Securities's CCXI Position: Q4 2022 in Review

Maven Securities sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 4,000 shares — an estimated $207K sold.

Maven Securities first reported a position in CCXI in Q4 2021 and held it in 3 quarters. The position peaked at $2.32M in Q4 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Maven Securities reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Maven Securities sold 4,000 ChemoCentryx, Inc. shares in Q4 2022, an estimated $207K.
Maven Securities first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 3 quarters.
Maven Securities's ChemoCentryx, Inc. position peaked at $2.32M in Q4 2021.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Maven Securities's 13F filing for Q4 2022, filed 14 Feb 2023.